Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Filings indexed 1,621 across all filing types
Latest filing 2025-09-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺(范宏宇)
Board/Management Information Classification · 95% confidence The document is a formal statement from a company's board nominating an independent director candidate. It details the qualifications, legal compliance, and independence criteria for the nominee, referencing various laws and regulatory requirements. There is no financial data, no report or results announcement, and no mention of a meeting or voting results. The content is about board/management information specifically related to director nomination and qualifications. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of voting results.
2025-09-28 Chinese
第四届董事会第四十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianyu Bio-Technology Co., Ltd. It details the meeting date, attendance, and specific board decisions such as canceling the supervisory board, adjusting board size, nominating directors, and proposing to hold a shareholders meeting. It references related announcements and governance changes but does not contain financial statements or detailed financial data. The document is primarily about board and management changes and governance matters. It is not a full annual or interim report, nor an earnings release or audit report. It fits best under Board/Management Information (MANG) as it announces board meeting resolutions and nominations for the new board.
2025-09-28 Chinese
独立董事候选人声明与承诺(范宏宇)
Regulatory Filings Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is not a financial report, earnings release, or any form of meeting material. It does not contain financial data or results, nor is it an announcement of voting results or management changes. It is a regulatory compliance statement related to board membership qualifications. Such documents typically fall under Regulatory Filings (RNS) as they are compliance-related disclosures that do not fit other specific categories.
2025-09-28 Chinese
独立董事提名人声明与承诺(刘榜)
Board/Management Information Classification · 95% confidence The document is a formal statement from a nominating party (the company's board) regarding the nomination of an independent director candidate. It details the qualifications, legal compliance, independence criteria, and absence of adverse records for the nominee. There is no financial data, no report of financial results, no voting results, no meeting materials, and no mention of any report publication. The document is a declaration related to board/management information, specifically about the nomination of a board member. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of a report.
2025-09-28 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and changes in the company's board of directors. It details the nomination of new board members, changes in board size, and compliance with relevant laws and regulations. There is no financial data or report content, but rather a formal disclosure about board restructuring and candidate qualifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-09-28 Chinese
董事和高级管理人员持股及其变动管理办法(2025年09月修订)
Governance Information Classification · 95% confidence The document is titled as a management method for the holdings and changes of shares by directors and senior management of the company. It contains detailed rules and regulations about shareholding, trading restrictions, reporting obligations, and compliance with securities laws. It does not contain financial statements, earnings data, or audit information. It is a governance-related document focusing on internal rules about shareholding and trading by company insiders. Therefore, it fits best under Governance Information (CGR). The document length is about 4770 characters, which is sufficient for a substantive governance report rather than a brief announcement or regulatory filing.
2025-09-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.